Novanta (NASDAQ:NOVT – Get Free Report) updated its fourth quarter 2026 earnings guidance on Tuesday. The company provided earnings per share guidance of 0.910-0.960 for the period, compared to the consensus estimate of 1.020. The company issued revenue guidance of $306.0 million-$312.0 million, compared to the consensus revenue estimate of $308.6 million. Novanta also updated its FY 2026 guidance to 3.660-3.710 EPS.
Novanta Stock Down 15.3%
NOVT opened at $123.71 on Wednesday. The business’s fifty day moving average is $141.80 and its two-hundred day moving average is $142.52. The company has a debt-to-equity ratio of 0.12, a quick ratio of 3.79 and a current ratio of 4.57. The company has a market cap of $4.68 billion, a price-to-earnings ratio of 94.44 and a beta of 1.71. Novanta has a one year low of $98.27 and a one year high of $176.38.
Novanta (NASDAQ:NOVT – Get Free Report) last announced its quarterly earnings results on Monday, November 9th. The technology company reported $1.05 earnings per share for the quarter, beating analysts’ consensus estimates of $0.97 by $0.08. The business had revenue of $305.01 million during the quarter, compared to analysts’ expectations of $301.02 million. Novanta had a return on equity of 10.62% and a net margin of 4.89%. The business’s revenue for the quarter was up 23.1% on a year-over-year basis. During the same quarter last year, the business posted $0.87 earnings per share. Analysts anticipate that Novanta will post 3.70 EPS for the current fiscal year.
Wall Street Analyst Weigh In
Several research analysts recently weighed in on the stock. Wall Street Zen raised shares of Novanta from a “hold” rating to a “buy” rating in a research note on Saturday. Robert W. Baird set a $194.00 target price on Novanta in a research note on Friday, August 7th. Weiss Ratings downgraded Novanta from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Tuesday. Finally, Zacks Research lowered Novanta from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 6th. One equities research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $194.00.
Check Out Our Latest Report on Novanta
Key Headlines Impacting Novanta
Here are the key news stories impacting Novanta this week:
- Positive Sentiment: Third-quarter revenue rose 23.1% year over year to $305 million, above estimates of about $301 million. Adjusted EPS of $1.05 also topped the $0.97 consensus. Customer bookings increased 29%, backlog reached $543 million, and operating cash flow improved to $39.3 million. Novanta third-quarter results
- Neutral Sentiment: Management outlined reported growth of more than 15% for 2027, while noting the company is working through a temporary Stockport disruption. The growth outlook is encouraging, though the disruption adds uncertainty. Novanta 2027 outlook
- Negative Sentiment: Fourth-quarter adjusted EPS guidance of $0.91–$0.96 is below analysts’ $1.02 estimate, even as revenue guidance of $306–$312 million brackets the $308.6 million consensus. Full-year adjusted EPS guidance is $3.66–$3.71. This softer earnings outlook may overshadow the quarterly beat. Novanta Q3 earnings call transcript
- Negative Sentiment: Despite growth in revenue, GAAP net income fell to $2.0 million from $10.7 million a year earlier; GAAP diluted EPS declined to $0.05 from $0.30. The gap between rising sales and lower reported profit could concern investors. Novanta Q3 financial details
About Novanta
Novanta develops and manufactures precision technologies used in medical and advanced industrial applications. Its products include photonics and laser components, precision motion-control systems, machine-vision technologies, and related equipment and software. The company’s technologies are used in areas such as medical and surgical systems, life sciences, robotics, and industrial automation. Novanta serves customers internationally, with operations and customers across North America, Europe, and Asia.
See Also
- Five stocks we like better than Novanta
- The Trade Desk Beats on Revenue, But the Fine Print Matters
- Poll Reveals: Which States Are Most Prepared for a Crisis? [2026]
- Why Kinder Morgan’s Chairman Just Bought $15 Million in Stock
- Rocket Lab’s Record Backlog Could Fuel a Rebound, But Neutron Raises the Stakes
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.
